S961 TFA is an high-affinity and selective insulin receptor ( IR ) antagonist with IC 50 s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.Appearance:SolidIn
S961 TFA is an high-affinity and selective insulin receptor ( IR ) antagonist with IC 50 s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.Appearance:SolidIn
S961 TFA is an high-affinity and selective insulin receptor ( IR ) antagonist with IC 50 s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.Appearance:SolidIn
S961 TFA is an high-affinity and selective insulin receptor ( IR ) antagonist with IC 50 s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.Appearance:SolidIn
S961 TFA is an high-affinity and selective insulin receptor ( IR ) antagonist with IC 50 s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.Appearance:SolidIn
S961 TFA is an high-affinity and selective insulin receptor ( IR ) antagonist with IC 50 s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.Appearance:SolidIn
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
NSC 694621 is a potent PCAF inhibitor, with an IC 50 of 5.71 µM ( PCAF/H3 1-21 ). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cellsIn VitroNSC 694621 (25 µM: 72 h) exhibits antiproliferative effect to SK-N-SH and
Ac-WEHD-AFC TFA is a fluorogenic caspase-1 substrate . Ac-WEHD-AFC TFA can measure caspase-1 fluorogenic activity and can be used for the research of tumor and inflammation.Appearance:SolidIC50&: Target:Caspase-1In Vitro:Guidelines (Following is
Ac-WEHD-AFC TFA is a fluorogenic caspase-1 substrate . Ac-WEHD-AFC TFA can measure caspase-1 fluorogenic activity and can be used for the research of tumor and inflammation.Appearance:SolidIC50&: Target:Caspase-1In Vitro:Guidelines (Following is